Kenvue’s second-quarter net sales saw a slight decline of 0.3%, compared to a 5.4% increase in the same period last year. Organic growth for the quarter was 1.5%, a sharp decrease from the 7.7% ...

Uber’s latest quarterly results, covering the period ended June 30, 2024, underscore the company’s continued strong performance. CEO Dara Khosrowshahi highlighted the significant strides Uber has made ...

On August 6, 2024, Tenax Therapeutics revealed that it has secured an oversubscribed private placement financing agreement. This deal is poised to provide the company with approximately $100 million ...

NVIDIA’s year-to-date performance has been impressive, with a gain of +102.87%. This reflects the company’s strong growth trajectory and its significant role in advancing AI technologies. The dramatic ...

SEC Filing Sparks 23% Rally in AgriFORCE’s (AGRI) Stock: Will the Company Meet Regulatory Deadlines?

Despite Jumia’s strong year-to-date performance of +54.16%, the recent stock price drop is starkly contrasted with the MSCI World Index’s modest gain of +6.83% over the same period. This discrepancy ...

Lumen Technologies has announced that it has secured $5 billion in new business, propelled by a surge in demand for high-capacity connectivity solutions, largely driven by the expanding needs of AI ...

The recent uptick in Maxeon Solar’s stock price, up 6.85% to $0.1450, comes as a positive signal amid its broader financial struggles. This increase is likely linked to the anticipation surrounding ...

Agape ATP Corporation’s stock saw a remarkable increase of +33.06% to $0.1650 during Tuesday’s premarket trading. This uptick comes despite the absence of any major announcements or market-moving news ...

VBI Vaccines Inc. experienced a significant surge in its stock price, climbing nearly 80% to $0.1130 in premarket trading on Tuesday. This jump is noteworthy given the company’s recent financial ...

Thoughtworks’ (TWKS) Stock Jumps 27% on $1.75 Billion Buyout Offer: What’s Next for the Tech Consultancy?

Cassava Sciences has seen a remarkable year-to-date performance, with its stock rising +78.86%. This impressive gain is a stark contrast to the broader market performance. For comparison, the S&P 500 ...